Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life

Hepatitis C virus (HCV) response to direct-acting antivirals (DAAs) may be influenced by the presence of resistance-associated substitutions (RASs). This study aimed to assess if NS5A baseline RAS-guided treatment enhances the rate of sustained viral response (SVR) in naïve HCV-infected patients in...

Descripción completa

Detalles Bibliográficos
Autores principales: Real, Luis M., Macías, Juan, Pérez, Ana B., Merino, Dolores, Granados, Rafael, Morano, Luis, Delgado, Marcial, Ríos, María J., Galera, Carlos, Deltoro, Miguel G., Merchante, Nicolás, García, Federico, Pineda, Juan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175866/
https://www.ncbi.nlm.nih.gov/pubmed/30297726
http://dx.doi.org/10.1038/s41598-018-33367-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175866/
https://www.ncbi.nlm.nih.gov/pubmed/30297726
http://dx.doi.org/10.1038/s41598-018-33367-1

Ejemplares similares